Results 11 to 20 of about 8,892 (155)

Oxcarbazepine Therapy for Complete Central Diabetes Insipidus

open access: yesCase Reports in Nephrology and Dialysis, 2018
Oxcarbazepine and carbamazepine cause hyponatremia by unknown mechanisms. We describe a patient with complete central diabetes insipidus and seizures who developed worsening hyponatremia when her dose of oxcarbazepine was increased.
Basmah Abdallah   +4 more
doaj   +1 more source

Three types of atrioventricular block induced by oxcarbazepine in a young adult

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Oxcarbazepine is a new antiepileptic drug that has been introduced recently. The side effects and properties of the drug are unique and largely unknown. Because oxcarbazepine is structurally similar to carbamazepine, it might have quinidine-like effects
Edibe Karasu, Ahmet Oguz Baktir
doaj   +1 more source

OXCARBAZEPINE [PDF]

open access: yesEpilepsia, 1999
Summary:The success of carbamazepine (CBZ) as a broad‐spectrum antiepileptic drug (AED) has led to its use as first‐line therapy in children and adults for partial and generalized tonic‐clonic seizures. The limitations of CBZ include toxicity in sensitive individuals, autoinduction, which requires dose adjustment when therapy is initiated, and chronic ...
openaire   +2 more sources

Management of alcohol withdrawal state in a patient with respiratory depression

open access: yesKerala Journal of Psychiatry, 2023
Alcohol withdrawal state is generally managed using benzodiazepines. In various studies, it was found that anticonvulsants, including oxcarbazepine, are as effective as benzodiazepines in managing alcohol withdrawal state. This case report highlights the
Arathy Nathan   +3 more
doaj   +1 more source

Sensitive Electrochemical Determination of Oxcarbazepine using Polymer Film Modified Glassy Carbon Electrode

open access: yesInternational Journal of Electrochemical Science, 2015
A glassy carbon electrode (GCE) is modified with electropolymerized film of p-aminobenzene sulfonic acid (p-ABSA) in pH 7.0 phosphate buffer solution (PBS).
Esra Rukiye Apaydın   +3 more
doaj   +1 more source

Oxcarbazepine

open access: yesReactions Weekly
Preuss CV, Randhawa G, Saadabadi A.
europepmc   +2 more sources

Pre- and Post-Treatment with Novel Antiepileptic Drug Oxcarbazepine Exerts Neuroprotective Effect in the Hippocampus in a Gerbil Model of Transient Global Cerebral Ischemia

open access: yesBrain Sciences, 2019
Oxcarbazepine, an antiepileptic drug, has been reported to modulate voltage-dependent sodium channels, and it is commonly used in epilepsy treatment.
Ji Hyeon Ahn   +11 more
doaj   +1 more source

Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions

open access: yesFrontiers in Pharmacology, 2022
Aim: To provide a comparison of genotyping for HLA risk alleles versus patch testing to determine which of these two tests is a better diagnostic tool for cutaneous hypersensitivity reactions caused by anti-seizure medication.Methods: A literature study ...
Lisanne E. N. Manson   +4 more
doaj   +1 more source

HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema

open access: yesFrontiers in Pharmacology, 2021
To characterize human leukocyte antigen (HLA) loci as risk factors in aromatic antiepileptic drug-induced maculopapular exanthema (AED-MPE). A case-control study was performed to investigate HLA loci involved in AED-MPE in a southern Han Chinese ...
Yi-Wu Shi   +24 more
doaj   +1 more source

Physiologically Based Pharmacokinetic Modeling of Oxcarbazepine to Characterize Its Disposition in Children with Obesity. [PDF]

open access: yesJ Clin Pharmacol
Abstract Oxcarbazepine (OXC) is a second‐generation antiseizure medication, effective through its active metabolite, 10‐mono‐hydroxy derivative (MHD). OXC is used as adjunctive therapy for focal‐onset and primary generalized tonic–clonic seizures, with recommended dosing based on age and body weight.
Maglalang PD   +12 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy